Skip to Main Content

Paper Details

Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs.
Clinicoecon Outcomes Res
2
2021

Datasets

Release 1.2